Treatment with methylnaltrexone is associated with increased survival in patients with advanced cancer

Ann Oncol 2016; 27: 2032–2038 (doi:10.1093/annonc/mdw317)

In the original article, Figure 2 and Figure 3 legends referred to red curves instead of green curves. The legends have now been corrected.